Expert Interview
A Second View: Examining the results of the Phase 3 ATTRibute-CM study of acoramidis in ATTR-CM by BridgeBio Pharma presented at International Symposium of Amyloidosis (ISA)
Ticker(s): BBIOInstitution: Yale
- Assistant Professor of Medicine in the Section of Cardiology at Yale.
- Advanced imaging cardiologist trained in infiltrative cardiomyopathies, specifically cardiac sarcoidosis and amyloidosis.
- Familiar with the findings from the VALOR-HCM and/or the EXPLORER-LTE clinical trials.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
